Impact of the FTO gene variation on fat oxidation and its potential influence on body weight in women with polycystic ovary syndrome

Clinical Endocrinology

Volumn 77, Issue 1, 2012, Pages 120-125

  Kowalska, Irina ^a   Adamska, Agnieszka ^a   Malecki, Maciej T ^b   Karczewska Kupczewska, Monika ^a   Nikolajuk, Agnieszka ^a   Szopa, Magdalena ^b   Gorska, Maria ^a   Straczkowski, Marek ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; TESTOSTERONE;

ADULT; ANTHROPOMETRY; ARTICLE; BODY WEIGHT; CALORIMETRY; CLINICAL EXAMINATION; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FAT MASS AND OBESITY ASSOCIATED GENE; FEMALE; FOLLITROPIN BLOOD LEVEL; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GLUCOSE CLAMP TECHNIQUE; HOMOZYGOTE; HUMAN; HYPERINSULINEMIA; LIPID OXIDATION; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENSTRUATION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX HORMONE DETERMINATION; TESTOSTERONE BLOOD LEVEL;

ADULT; ALLELES; BODY WEIGHT; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; LIPID METABOLISM; LIPID PEROXIDATION; OXIDATION-REDUCTION; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; YOUNG ADULT;

EID: 84862021389     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04379.x     Document Type: Article

References (31)

1. Goodarzi, M.O., Dumesic, D.A., Chazenbalk, G. et al. (2011) Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nature Reviews. Endocrinology, 7, 219-231.
2. March, V.A., Moore, V.M., Willson, K.J. et al. (2010) The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Human Reproduction, 25, 544-551.
3. Frayling, T.M., Timpson, N.J., Weedom, M.N. et al. (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science, 316, 889-894. (Pubitemid 46764279)
4. Scuteri, A., Sanna, S., Chen, W.M. et al. (2007) Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity related traits. PLoS Genetics, 3, e115.
5. Kowalska, I., Malecki, M.T., Straczkowski, M. et al. (2009) The effect of FTO gene on body weight, fat mass and insulin sensitivity in women with polycystic ovary syndrome where its role may be larger than in other phenotypes. Diabetes and Metabolism, 35, 328-331.
6. Evens, K.G., Jones, M.R., Ankener, W. et al. (2011) FTO and MCR4 gene variants are associated with obesity in polycystic ovary syndrome. PLoS ONE, 6, e16390.
7. Fisher, J., Koch, L., Emmerling, C. et al. (2009) Inactivation of the Fto gene protects from obesity. Nature, 458, 894-898.
8. Church, C., Moir, L., McMurray, F. et al. (2010) Overexpression in Fto leads to increased food intake and obesity. Nature Genetics, 42, 1086-1092.
9. Wardle, J., Carnell, S., Haworth, C.M.A. et al. (2008) Obesity associated genetic variation in FTO is associated with diminished satiety. Journal of Clinical Endocrinology and Metabolism, 93, 3640-3643.
10. Cecil, J.E., Tavendale, R., Watt, P. et al. (2008) An obesity-associated FTO gene variant and increased energy intake in children. New England Journal of Medicine, 359, 2558-2566.
11. Speakman, J.R., Rance, K.A. & Johnstone, A.M. (2008) Polymorphisms of FTO gene are associated with variation in energy intake, but not energy expenditure. Obesity, 16, 1961-1965.
12. Berentzen, T., Kring, S.I., Holst, C. et al. (2008) Lack of association of fatness-related gene variants with energy expenditure or physical activity. Journal of Clinical Endocrinology and Metabolism, 93, 2904-2908. (Pubitemid 352008569)
13. Berulava, T. & Horsthemke, B. (2010) The obesity-associated SNPs in intron 1 of FTO gene affect primary transcript levels. European Journal of Human Genetics, 18, 1054-1056.
14. Gerken, T., Girard, C.A., Tung, Y.C. et al. (2007) The obesity - associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science, 318, 1469-1472. (Pubitemid 350208961)
15. Whalen, K., Sjolin, E. & Hoffsted, J. (2008) The common rs9939609 gene variant of fat mass and obesity-associated gene FTO is related to fat cell lipolysis. Journal of Lipid Research 409, 607-611.
16. Grunnet, L.G., Nilson, E., Ling, C. et al. (2009) Regulation and function of FTO mRNA expression in human skeletal muscle and subcutaneous adipose tissue. Diabetes, 58, 2402-2408.
17. Kelly, D. & Mandarino, L. (2000) Fuel selection in human skeletal muscle and insulin resistance: a reexamination. Diabetes, 49, 677-683.
18. Corpeleijn, E., Petersen, L., Holst, C. et al. (2010) Obesity related polymorphism and their associations with the ability to regulate fat oxidation in obese Europeans: the NUGENOB Study. Obesity, 18, 1369-1377.
19. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long term health risk related to polycystic ovary syndrome (PCOS). Human Reproduction, 19, 41-47.
20. Kowalska, I., Straczkowski, M., Nikolajuk, A. et al. (2007) Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Human Reproduction, 22, 1824-1829. (Pubitemid 47062747)
21. DeFronzo, R.A., Tobin, J.D. & Andres, R. (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. American Journal of Physiology, 237, E214-E223. (Pubitemid 9249478)
22. Straczkowski, M., Kowalska, I., Nikolajuk, A. et al. (2004) Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle. Diabetes, 53, 1215-1221. (Pubitemid 38569006)
23. Frayn, K.N. (1983) Calculation of substrate oxidation rates in vivo from gaseous exchange. Journal of Applied Physiology, 55, 628-634.
24. Vermeulen, A., Veronck, L., Kaufman, J.M. et al. (1999) A critical evaluation of simple methods fort he estimation of free testosterone in humans. Journal of Clinical Endocrinology and Metabolism, 84, 3666-3672. (Pubitemid 30645223)
25. Hojlund, K., Glintborg, D., Andersen, N.R. et al. (2008) Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle in women with polycystic ovary syndrome is reversed by pioglitazone treatment. Diabetes, 57, 357-366.
26. Svendsen, P.F., Nilas, L., Norgaard, K. et al. (2008) Obesity, body composition and metabolic disturbances in polycytic ovary syndrome. Human Reproduction, 23, 2113-2121.
27. Shulman, G.L., Rothman, L., Jue, T. et al. (1990) Quantification of muscle glycogen synthesis in normal subjects and subjects with non-insulin dependent diabetes by 13C nuclear magnetic resonance spectroscopy. New England Journal of Medicine, 322, 223-228. (Pubitemid 20034509)
28. Colberg, S.R., Simoneau, J.A., Thaete, F.L. et al. (1995) Skeletal muscle utilization of free fatty acids in women with visceral obesity. The Journal of Clinical Investigation, 95, 1846-1853.
29. Kelley, D., Mokan, M. & Veneman, T. (1994) Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus. Metabolism, 43, 1549-1557. (Pubitemid 24382707)
30. Zurlo, F., Lillioja, S., Esposito-Del Puente, A. et al. (1990) Low ratio of fat to carbohydrate oxidation as a predictor of weight gain: study of 24 h RQ. American Journal of Physiology, 259, E560-E567.
31. Barber, M.T., Bennet, A.J., Groves, C.J. et al. (2008) Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome. Diabetologia, 51, 1153-1158.